Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

INSIGHT

Insight logo

The Innovative Network for Sight Research (INSIGHT)  was a CDC-funded collaborative vision research network of investigators at the Johns Hopkins University, University of Alabama at Birmingham, University of Miami, and Wills Eye Institute. From 2010-2016 INSIGHT’s focus was to assess and evaluate system-level and individual-level factors that impact access to, and the quality of eye care. Site-specific and network studies investigated barriers and enablers to the delivery of efficacious and cost-effective eye care that prevent vision loss and promote eye health.

Research Objectives: (1) to assess and evaluate system-level and individual-level factors that impact access to, and the quality of eye care; (2) to identify barriers and enablers to the delivery of efficacious and cost-effective eye care

INSIGHT Translational Research Centers (TRCs) and site-specific studies:

Johns Hopkins University (PI: David S. Friedman, MD, PhD)

  1. SEE, Proyecto Ver and ProVision: Assess factors (personal /perceived system) associated with adherence to best eye care practices for cataract and diabetic retinopathy
  2. Assessment of Uptake of Glaucoma Services Among Medicare Participants
  3. NHANES: Identify barriers and enablers for obtaining proper screening and treatment for diabetic retinopathy

University of Alabama at Birmingham (PI: Cynthia Owsley, PhD, MSPH)

  1. Eye Care Utilization among Diabetes Patients in a County Hospital Setting: Prevalence and Barriers
  2. Rehabilitation Referral for Patients with Irreversible Vision Impairment in a County Hospital Setting: Prevalence and Barriers

University of Miami (PI: David J. Lee, PhD)

  1. BPEI Chart Review: Using similar data collection methodology as the Wills Eye Study team, undertake comprehensive analysis of BPEI medical and billing records to assess and evaluate system-level and individual-level factors that impact access to and quality of vision care in patients with diabetes.
  2. Hispanic Community Health Ancillary Ocular Study: In a population-based sub-sample of Hispanics aged 40y and older, document healthcare utilization and barriers to care, knowledge of ocular healthcare visit recommendations and risk factors, and prevalence of reported ocular conditions and risk factors.

Wills Eye Health System (PI: Julia Haller, MD)

  1. Retrospective analysis of existing ophthalmic data sets to assess and evaluate system-level and individual-level factors that impact access to and quality of vision care in patients with diabetes
  2. Implement a telephone-based and educational intervention to improve DFE follow-up adherence in African Americans with diabetes utilizing a prospective, cluster-based, randomized cohort design.

Collaborative/network Study

Diabetic retinopathy screening: Telemedicine; Digital photo; Vision screening; Cost-effective

Settings: Pharmacy, Public clinic

Publications

Aleo CL, Hark LA, Leiby B, Dai Y, Murchison AP, Martinez P, Haller JA. Ophthalmic patients’ utilization of technology and social media: an assessment to improve quality of care. Telemed J E Health. 2014; Oct;20(10):887-892. PMID: 25188532.

Aleo CL, Murchison AP, Dai Y, Hark LA, Mayro EL, Collymore B, Haller JA. Improving eye care follow-up adherence in diabetic patients with ocular abnormalities: the effectiveness of patient contracts in a free, pharmacy-based eye screening. Public Health. 2015; Jul;129(7):996-999. PMID: 26119987.

Evaluation of a Web-Based Training in Smoking Cessation Counseling Targeting U.S. Eye-Care Professionals [PDF – 1 MB]

Owsley C, McGwin G Jr, Lee DJ, Lam BL, Friedman DS, Gower EW, Haller JA, Hark LA, Saaddine J; Innovative Network for Sight (INSIGHT) Research Group. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015 Feb;133(2):174-81. doi: 10.1001/jamaophthalmol.2014.4652.

Murchison AP, Friedman DS, Gower EW, Haller JA, Lam BL, Lee DJ, McGwin G Jr, Owsley C, Saaddine J, Insight Study Group. A Multi-Center Diabetes Eye Screening Study in Community Settings: Study Design and Methodology. Ophthalmic Epidemiol. 2016;23(2):109-15. doi: 10.3109/09286586.2015.1099682. Epub 2016 Mar 7.

Murchison AP, Haller JA, Mayro E, Hark L, Gower E, Huisingh C, Rhodes L, Friedman DS, Lee DJ, Lam BL; Innovative Network for Sight (INSIGHT) Research Group. Reaching the unreachable: novel approaches to telemedicine screening of underserved populations for vitreoretinal disease. Curr Eye Res. 2017;42(7):963-970. PMID: 28506091.

Pizzi LT, Tran J, Shafa A, Waisbourd M, Hark L, Murchison AP, Dai Y, Mayro EL, Haller JA. Effectiveness and cost of a personalized reminder intervention to improve adherence to glaucoma care. Applied Health Econ Health Policy 2016; 29:1-2. PMID: 26924099.

Pizzi LT, Zangalli CS, Murchison AP, Hale N, Hark LA, Dai Y, Leiby BE, Haller JA. Prospective randomized controlled trial comparing the outcomes and costs of two eye care adherence interventions in diabetes patients. Appl Health Econ Health Policy. 2015; Apr;13(2):253-263. PMID: 25786858.

Rovner BW, Haller JA, Casten RJ, Murchison AP, Hark LA. Depression and risk perceptions in older African Americans with diabetes. Diabetes Spectr. 2014; May;27(2):114-118. PMID: 26246767.

Storey P, Murchison AP, Dai Y, Hark LA, Pizzi LT, Leiby BE, Haller JA. Comparing methodologies for imputing ethnicity in an urban ophthalmology clinic. Ophthalmic Epidemiol. 2014; Apr;21(2):106-110. PMID: 24568574.

Storey PP, Murchison AP, Pizzi LT, Hark LA, Dai Y, Leiby BE, Haller JA. Impact of physician communication on diabetic eye examination adherence: results from a retrospective cohort analysis. Retina. 2016 Jan;36(1):20-7. PMID: 26098386.

Zangalli CS, Murchison AP, Hale N, Hark LA, Pizzi LT, Dai Y, Leiby BE, Haller JA. An education- and telephone-based intervention to improve follow-up to vision care in patients with diabetes: a prospective, single-blinded, randomized trial. Am J Med Qual. 2014; Mar-Apr;31(2):156-161. PMID: 25270737.

TOP